A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study treatment period is 15 days in length and includes patients with pituitary
Cushing's disease who are candidates for surgical intervention as well as and patients who
have recurrent Cushing's post operatively.